AXA Stock: Shares Rise Following Record 2025 Annual Results

Record Annual Results Unveiled

This morning, AXA unveiled its 2025 annual accounts, described as record-breaking. The operational result excluding asset management grew by 9%, while the overall operational result reached 8.4 billion euros, up by 6%. The net result amounted to 9.8 billion euros, marking a 26% increase year-over-year. This performance is based on several pillars. The property and casualty insurance shows particularly strong dynamics, supported by ongoing pricing discipline that continues to yield results. The life and health business also contributes to this trajectory with a notable improvement in its margins. The combination of these two drivers illustrates the group's ability to generate profitability in a still high-interest rate environment. These results are part of the group's financial calendar, with the general assembly scheduled for April 30. Today's announcement was a major event for shareholders, as the stock performance over the past year has been nearly 8%.

Technical Perspective: Breaking Resistance

From a technical standpoint, breaking through the resistance level at 40.21 euros is a significant signal. The stock price, now at 40.53 euros, has surpassed this threshold for the first time in several sessions, indicating a short-term bullish momentum resumption. This progression is accompanied by a move above the 200-day moving average, set at 40.24 euros, a closely monitored indicator by fund managers to assess the underlying trend of a stock. As long as the price remains above this level, the outlook remains favorable. The Relative Strength Index (RSI) at 51 is in a neutral zone, indicating that the stock is neither overbought nor oversold. This moderate reading leaves room for potential progress without signs of excessive tension. Over the past seven days, the increase reached 4.59%, while over three months, the cumulative gain is 5.82%. Monthly volatility remains contained at 5.91%, confirming a relatively orderly evolution of the stock despite the catalyst represented by today's publication.